$0.25
-0.02 (-8.38%)
Open$0.28
Previous Close$0.27
Day High$0.28
Day Low$0.23
52W High$3.23
52W Low$0.30
Volume—
Avg Volume164.3K
Market Cap4.45M
P/E Ratio—
EPS$-2.11
SectorPharmaceuticals
Analyst Ratings
Strong Sell
7 analysts
Price Target
+8,937.0% upside
Current
$0.25
$0.25
Target
$22.24
$22.24
$15.33
$22.24 avg
$34.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.01M | 4.81M | 4.77M |
| Net Income | 16.47M | 633.7K | 796.1K |
| Profit Margin | 328.7% | 13.2% | 16.7% |
| EBITDA | -32,097,409 | 1.15M | 1.15M |
| Free Cash Flow | — | 870.8K | 772.5K |
| Rev Growth | +131.1% | +22.7% | +21.0% |
| Debt/Equity | — | 0.81 | 0.64 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,368.84 | +0.30% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $274.87 | +0.94% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $147.01 | +0.05% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.30 | -1.94% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $62.89 | -0.38% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $79.81 | -2.80% | 12.3 | 32.24B |